D-0460-2025 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0460-2025 was initiated by AvKARE on May 13, 2025 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules The recall status is ongoing. Affected quantity: 3,817 50-count cartons.

Recall details

Product Type
Drugs
Report Date
Jun 18, 2025
Initiation Date
May 13, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,817 50-count cartons

Product description

Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-169-15

Reason for recall

Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules

Distribution pattern

Nationwide in the USA

Code information

Lot #47881, Exp 05/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0460-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0460-2025. Report a data issue: hello@regdatalab.com.